FDA
label_change
· 2011-06-03
FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) filed by Novartis Pharmaceuticals Corporation. The action typically i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIOVAN HCT (VALSARTAN AND HYDROCHLOROTHIAZIDE)